Hôpital Salengro, Intensive care departement, CHRU
Lille, France
NCT Number: NCT02841501
This is a prospective case-control physiopathological study, which main objective is to determine the genetic host factors predisposing to candidemia. Secondary objectives are to develop new diagnosis tools using the biological collection, to describe and update epidemiology, to analyse the influence of genetic polymorphisms on prognosis.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lille, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An analysis of the SNPs (single nucleotide polymorphism) of 25 candidate genes will be performed. This analysis will be completed by a genome wide association study.
Time frame: In the 48-72 hours following the positive blood culture
University Hospital, Lille
Other
Genetic Susceptibility Factors Involved in Candidemia: Case-control Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04368559
Aspergillus, Bacterial Infections and Mycoses
Birmingham, Alabama, United States
View Trial DetailsNCT07422155
Bacterial Infections and Mycoses, Candidemia
Ljubljana, Slovenia
View Trial DetailsNCT00608335
Bacterial Infections and Mycoses, Candidemia
Los Angeles, California, United States
View Trial DetailsNCT02734862
Bacterial Infections and Mycoses, Candidemia
Birmingham, Alabama, United States
View Trial Details